Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...

Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

A company presentation to the SEC indicated that the listing is expected to generate approximately $463 million (₹4,064 crore ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Q4 2024 Earnings Call Transcript February 13, 2025 Operator: Hello, everyone, and welcome to today’s Corebridge Financial ...

Who would’ve thought a big, bureaucratic listed company could be responsible for one of Australia’s best VC investments?

Bally's announced a $250 million public offering last month for shares of its massive Chicago casino project, but only to ...

Thyssenkrupp aims to "finalise" a planned spin-off of a minority stake in its warship division in the course of 2025, the ...

IPO (Initial Public Offering ... During a November 2024 investor presentation, Applied Digital reported that it had more than 1 gigawatt of projects in its pipeline. Although accredited investors ...

IPO: Next week is going to start with a bang. During this time 9 new IPOs will open. Out of these 3 IPOs are from the main ...

The company has expanded at a 30-35% compound annual growth rate over the past five years since inception. It offers ...

Citi, which argued that there was not enough investor support to make the proposed IPO viable ... we may have inadvertently included in our presentation or conveyed during any of our calls ...